Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04870944
Title CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Children's Oncology Group
Indications

diffuse midline glioma, H3 K27M-mutant

lymphoma

Advanced Solid Tumor

osteosarcoma

central nervous system cancer

Therapies

CBL0137

Age Groups: child | adult
Covered Countries USA


No variant requirements are available.